Asia Today: India reports 63,000 new cases, China tests 4.2M

NEW DELHI (AP) — India has confirmed more than 63,000 new cases of the coronavirus, an increase of over 8,000 from the previous day but still far fewer than it was reporting a month ago, when the virus was at its peak in the country.

The Health Ministry reported 63,509 new cases on Wednesday, raising India’s total to more than 7.2 million, second in the world behind the U.S. The ministry also reported 730 fatalities in the past 24 hours, raising the death toll to 110,586. The country was seeing more than 1,000 deaths per day last month.

According to the Health Ministry, India’s average number of daily cases dropped to 72,576 last week from 92,830 during the week of Sept. 9-15, when the virus peaked. Over the last month, the country has been seeing a trend of declining cases on a week-to-week basis.

On Tuesday, India registered 55,342 new cases, its lowest single-day tally since mid-August.

In other developments in the Asia-Pacific region:

— China says it has carried out more than 4.2 million tests in the northern port city of Qingdao, with no new cases of the coronavirus among the almost 2 million results received. The city has reported a total of 12 cases, six with symptoms and six without, since the new outbreak was first spotted over the weekend at a hospital. China on Wednesday reported 27 new cases, including 13 of local transmission and 14 brought from outside the country. The local cases included seven that had been shifted to confirmed from asymptomatic. It wasn’t immediately clear whether any of those involved cases reported in Qingdao. China has reported a total of 4,634 deaths among 85,611 confirmed cases of COVID-19.

___

Follow AP’s pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak

7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle

October 2, 2020, may not rank as one of those “where were you when” moments. But when news broke that the President of the United States and the First Lady tested positive for the novel coronavirus, there was certainly a sense that we were living through a historical moment (as if we already were not).

Over the following days, several biotech and pharmaceutical companies took the headlines. However, these weren’t the vaccine stocks that investors have committed to memory. These were companies that are leading the race for antiviral therapeutics.

And with a very high profile proof of concept, therapeutics may have had their moment. It’s far too early to say whether these drugs truly carry the answer. But from the outset of the pandemic, there has been a feeling that therapeutics may carry the ultimate solution to neutralizing the most severe effects of the novel coronavirus.

As you might expect, there is no shortage of companies in the therapeutic discussion. In this special presentation, we’re highlighting seven companies that you should be paying close attention to. If therapeutics nudge ahead of a vaccine, these stocks are likely to make strong upward moves.

View the “7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle”.

Stockmarkets and cryptocurrency quotes, Stockmarkets Insights